Stericycle, Inc. Profile Avatar - Palmy Investing

Stericycle, Inc.

Stericycle, Inc., together with its subsidiaries, provides regulated and compliance solutions in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including sharps disposable and management soluti…
Waste Management
US, Bannockburn [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 17% Weak
Leverage & Liquidity 17% Weak
Per Share Metrics 67% Positive
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 1.41 60.75 59.90
Graham Fair Price -6.33 9.31 9.94
PEG 6026.26 -7.35 0.12
Price/Book 5.07 1.91 1.82
Price/Cash Flow -77.50 -49.36 219.34
Prices/Earnings 19.52 91.93 76.92
Price/Sales 3.04 7.24 7.03
Price/FCF -77.50 -49.36 219.34
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -2.75 0.34 0.35
Operating Margin 7.47 0.09 0.08
ROA -13.42 < 0.005 < 0.005
ROE < 0.005 < 0.005 -12.09
ROIC < 0.005 < 0.005 -7.13
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ 0.08 < 0.005 1947.74
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ 1.15 0.10 -91.68
EPS QOQ 6.41 -0.12 -98.05
FCF QOQ 210.00 -5.67 -97.30
Revenue QOQ < 0.005 0.02 761.98
Naive Interpretation member
03 - Financial Growth · Weak
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 0.00 < 0.005 100.00
Days Sales Outstanding (DSO) 76.46 83.44 9.12
Inventory Turnover 0.00 437800000.00 100.00
Debt/Capitalization 0.36 0.38 6.01
Quick Ratio 0.82 0.99 20.46
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 27.27 27.24 -0.10
Cash 0.38 0.33 -12.28
Capex -0.31 -0.47 -47.95
Free Cash Flow 0.23 -1.05 366.48
Revenue 7.05 7.18 1.87
Naive Interpretation member
05 - Per Share Metrics · Positive
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 0.91 1.09 19.17
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 16.53 17.20 4.01
Naive Interpretation Member
06 - Financial Health · Bad
End of SRCL's Analysis
CIK: 861878 CUSIP: 858912108 ISIN: US8589121081 LEI: - UEI: -
Secondary Listings
SRCL has no secondary listings inside our databases.